Skip to content
Home/Companies/Healthcare/VISUfarma
VISUfarma

VISUfarma

Healthcare·UK·Exited 2026·Held 10yr
Entry
2016
Hold
10yr
Exit
2026

Who owns VISUfarma?

VISUfarma was owned by GHO Capital through GHO Capital Fund I LP (2015 vintage) from 2016 to 2026, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

GHO Capital
Investor
GHO Capital
GHO Capital Fund I LP · 2015 · Buyout

Key facts

HQUK
SectorHealthcare
Websitewww.visufarma.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2026

More from GHO Capital Fund I LP

Other portfolio companies in the same fund.

BioAgilytix
Exited 2021
BiotechUS· 2018
to
Linimed-Fazmed
Active
HealthcareGermany· 2018
Caprion Biosciences
Exited 2019
BiotechCanada· 2016
to
DNA Diagnostics Center
Exited 2021
HealthcareUS· 2015
to
Quotient Clinical
Active
HealthcareUK· 2015
Quotient Sciences
Exited 2019
PharmaUK· 2015
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track VISUfarma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy VISUfarma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on VISUfarma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue